神经内科超说明书用药循证医学甄鉴
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Analysis of Off-label Medicine Use in Department of Neurology
  • 作者:王蒙蒙 ; 许静 ; 马春来
  • 英文作者:WANG Meng-meng;XU Jing;MA Chun-lai;Department of Pharmacy, Children's Hospital of Nanjing Medical University;Department of Pharmacy, Huashan Hospital, Fudan University;
  • 关键词:神经内科 ; 超说明书用药 ; 循证依据
  • 英文关键词:Neurology department;;Off-label use;;Evidence-based proofs
  • 中文刊名:YXLY
  • 英文刊名:Pharmaceutical and Clinical Research
  • 机构:南京医科大学附属儿童医院药学部;复旦大学附属华山医院药学部;
  • 出版日期:2017-10-15
  • 出版单位:药学与临床研究
  • 年:2017
  • 期:v.25
  • 语种:中文;
  • 页:YXLY201705020
  • 页数:4
  • CN:05
  • ISSN:32-1773/R
  • 分类号:77-80
摘要
为了解某院神经内科超说明书用药情况和用药合理性,选取该院神经内科病区2016年6月~2016年12月共2988条长期医嘱,进行超说明书用药循证依据分析。结果发现神经内科超说明书用药均有循证医学证据支持,但证据质量存在差异。建议在实际应用中应充分评估超说明用药的有效性和安全性,尽量规避风险。
        To investigate the rationality of off-label drug use in the department of neurology in a hospital, totally 2988 inpatient medication orders selected from June 2016 to December 2016 were analyzed. The rationality of the off-label drug use was evaluated according to evidence-based medical proofs. It was found that all the off-label uses of medications in neurology inpatients had evidence-based supports. But the varying quality of those evidences should not be neglected. In practice, the rationality and effectiveness of off-label use should be fully evaluated to avoid or minimize risks.
引文
[1]菅凌燕,何晓静,汪珊.国内外超说明书用药的现状及其启示[J].中华医院管理杂志,2015,31(1):46-9.
    [2]中国药理学会治疗药物监测研究专业委员会药品风险管理学组.超说明书用药专家共识[J].药物不良反应杂志,2015,17(2):101-3.
    [3]中国免疫学会神经免疫学分会.中国视神经脊髓炎谱系病诊断与治疗指南[J].中国神经免疫学和神经病学杂志,2016,23(3):155-66.
    [4]Sellner J,Boggild M,Clanet M,et al.EFNS guidelines on diagnosis and management of neuromyelitis optica[J].Eur J Neurol,2010,17(8):1019-32.
    [5]中华医学会神经病学分会神经免疫学组,中国免疫学会神经免疫学分会.中国重症肌无力诊断和治疗指南[J].中华神经科杂志,2015,48(11):934-40.
    [6]Sussman J,Farrugia ME,Maddison P,et al.Myasthenia gravis:Association of British Neurologists’Management Guidelines[J].Pract Neurol,2015,15(3):199-206.
    [7]Nosadini M,Mohammad SS,Ramanathan S,et al.Immune therapy in autoimmune encephalitis:a systematic review[J].Expert Rev Neurother,2015,15(12):1391-419.
    [8]Centre for Clinical Practice at NICE(UK).Neuropathic Pain:The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist Settings[DB/OL].London:National Institute for Health and Care Excellence,2013.https://www.guidance.nice.org.uk/cg173
    [9]中华医学会疼痛学分会头面痛学组,中国医师协会神经内科医师分会,疼痛和感觉障碍专委会.中国偏头痛防治指南[J].中国疼痛医学杂志,2016,22(10):721-7.
    [10]Soliven B,Rezania K,Gundogdu B,et al.Terbutaline in myasthenia gravis:A pilot study[J].J Neurol Sci,2009,277(1-2):150-4.
    [11]Choi KH,Park MS,Kim HS,et al.Alpha-lipoic acid treatment is neurorestorative and promotes functional recovery after stroke in rats[J].Mol Brain,2015,8:9.
    [12]Shibuya M,Hirai S,Seto M.Effects of fasudil in acute ischemic stroke:results of a prospective placebocontrolled double-blind trial[J].J Neurol Sci,2005,238(1-2):31-9.
    [13]王强,张玉萍,詹媛.丹参多酚酸盐注射液治疗急性脑梗死的临床疗效观察[J].临床合理用药,2016,9(14):29-30.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700